NEW South African weight-loss drug: Hamba kahle Ozempic

NEW South African weight-loss drug: Hamba kahle Ozempic

A new South African weight-loss drug – Mounjaro – is ready to undercut the big boy, Ozempic. Aspen Pharmacare this week celebrated receiving regulatory approval, effective from October 2025. As such, the South African Health Products Regulatory Authority (SAHPRA) has approved once-weekly, prescription-only treatment with the South African weight-loss drug. However, the regulator insists the drug is only an adjunct for chronic weight management. …

SA Company Takes Aim At Ozempic With Local Approval Of New Weight-Loss Jab

[Image:here] Aspen is stepping into the heavyweight ring of weight-loss drugs, and its new contender is ready to take a swing at Ozempic. The South African pharmaceutical giant has officially received regulatory approval for Mounjaro (tirzepatide), a once-weekly prescription-only injection designed to help with chronic weight management, per BusinessTech. The green light from the South African Health Products Regulatory Authority (SAHPRA) means …